Search Orphan Drug Designations and Approvals
-
Generic Name: | daratumumab |
---|---|
Date Designated: | 08/06/2015 |
Orphan Designation: | Treatment of follicular lymphoma |
Orphan Designation Status: | Designated/Designation Withdrawn or Revoked |
Date Designation Withdrawn or Revoked: | 09/20/2021 |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Janssen Research & Development, LLC 1400 McKean Road P.O. Box 776 Spring House, Pennsylvania 19477 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-